RT Journal Article SR Electronic T1 â–¼Ezetimibe - a new cholesterol-lowering drug JF Drug and Therapeutics Bulletin JO Drug Ther Bull FD BMJ Publishing Group Ltd SP 65 OP 67 DO 10.1136/dtb.2004.42965 VO 42 IS 9 YR 2004 UL http://dtb.bmj.com/content/42/9/65.abstract AB Relevant BNF section: 2.12Use of statin therapy is a key first-line approach in preventing coronary heart disease events and stroke in people at increased risk of developing such complications. â–¼Ezetimibe (Ezetrol - MSD-Schering-Plough), the first licensed azetidinone drug, is being promoted as an adjunct to statin therapy to achieve greater reductions in blood cholesterol concentrations than occur with a statin alone. Here we review ezetimibe and consider its place in clinical practice.